Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4

Molecular and Cellular Biology

Volumn 23, Issue 11, 2003, Pages 3872-3883

  Björnsson, Jon Mar ^a   Larsson, Nina ^a   Brun, Ann C M ^a   Magnusson, Mattias ^a   Andersson, Elisabet ^a   Lundström, Patrik ^a   Larsson, Jonas ^a   Repetowska, Ewa ^a   Ehinger, Mats ^a   Humphries, R Keith ^b,c   Karlsson, Stefan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; FLUOROURACIL; HOMEODOMAIN PROTEIN; HOX PROTEIN; HOXB3 PROTEIN; HOXB4 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CYCLE; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; EMBRYO; FETUS; FETUS DEVELOPMENT; GENE OVEREXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC TISSUE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POPULATION DYNAMICS; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANTIMETABOLITES; BONE MARROW TRANSPLANTATION; CELL DIVISION; FLUOROURACIL; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; LIVER; MICE; MICE, KNOCKOUT; TRANSCRIPTION FACTORS; XENOPUS PROTEINS;

ANIMALIA;

EID: 0038246245     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.11.3872-3883.2003     Document Type: Article

References (64)

1. Antonchuk, J., G. Sauvageau, and R. K. Humphries. 2001. HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp. Hematol. 29:1125-1134.
2. Antonchuk, J., G. Sauvageau, and R. K. Humphries. 2002. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39-45.
3. Bhardwaj, G., B. Murdoch, D. Wu, D. P. Baker, K. P. Williams, K. Chadwick, L. E. Ling, F. N. Karanu, and M. Bhatia. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2:172-180.
4. Bhatia, M., D. Bonnet, U. Kapp, J. C. Wang, B. Murdoch, and J. E. Dick. 1997. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186:619-624.
5. Bjornsson, J. M., E. Andersson, P. Lundstrom, N. Larsson, X. Xu, E. Repetowska, R. K. Humphries, and S. Karlsson. 2001. Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10. Blood 98:3301-3308.
6. a. Björnsson, J. M., A. Brun, N. Larsson, E. Repetowska, and S. Karlsson. 2001. HoxB4 deficiency causes reduced cellularity in hematopoietic organs and diminished proliferative capacity response of primitive hematopoietic progenitors. Blood 98:69a. (Abstract.)
7. Boulet, A. M., and M. R. Capecchi. 1996. Targeted disruption of hoxc-4 causes esophageal defects and vertebral transformations. Dev. Biol. 177:232-249.
8. Bromleigh, V. C., and L. P. Freedman. 2000. p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells. Genes Dev. 14:2581-2586.
9. a. Brun, A., X. Fan, K. Humphries, and S. Karlsson. 2001. The effects of HoxB4 in human primitive hematopoietic progenitors are concentration dependent: high levels of HoxB4 lead to increased myeloid differentiation and a reduction in proliferative capacity. Blood 98:66a. (Abstract.)
10. Buske, C., M. Feuring-Buske, C. Abramovich, K. Spiekermann, C. J. Eaves, L. Coulombel, G. Sauvageau, D. E. Hogge, and R. K. Humphries. 2002. Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 100:862-868.
11. Buske, C., M. Feuring-Buske, J. Antonchuk, P. Rosten, D. E. Hogge, C. J. Eaves, and R. K. Humphries. 2001. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood 97:2286-2292.
12. Buske, C., and R. K. Humphries. 2000. Homeobox genes in leukemogenesis, Int. J. Hematol. 71:301-308.
13. cip1/waf1. Science 287:1804-1808.
14. Conneally, E., J. Cashman, A. Petzer, and C. Eaves. 1997. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 94:9836-9841.
15. + cells induces an in vitro expansion of clonogenic and early progenitors. Exp. Hematol. 28:569-574.
16. DiMartino, J. F., L. Selleri, D. Traver, M. T. Firpo, J. Rhee, R. Warnke, S. O'Gorman, I. L. Weissman, and M. L. Cleary. 2001. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98:618-626.
17. a. Eklund, E. A., R. Kakar, and A. Jalava. 2000. HoxA10 recruits transcriptional co-repressors to the CYBB and NCF2 genes. Blood 96:286a. (Abstract.)
18. Giannola, D. M., W. D. Shlomchik, M. Jegathesan, D. Liebowitz, C. S. Abrams, T. Kadesch, A. Dancis, and S. G. Emerson. 2000. Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2. J. Exp. Med. 192:1479-1490.
19. Gould, A., A. Morrison, G. Sproat, R. A. White, and R. Krumlauf. 1997. Positive cross-regulation and enhancer sharing: two mechanisms for specifying overlapping Hox expression patterns. Genes Dev. 11:900-913.
20. Graham, A., N. Papalopulu, J. Lorimer, J. H. McVey, E. G. Tuddenham, and R. Krumlauf. 1988. Characterization of a murine homeo box gene, Hox-2.6, related to the Drosophila Deformed gene. Genes Dev. 2:1424-1438.
21. Gu, H., Y. R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164.
22. Horan, G. S., R. Ramirez-Solis, M. S. Featherstone, D. J. Wolgemuth, A. Bradley, and R. R. Behringer. 1995. Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev. 9:1667-1677.
23. Izon, D. J., S. Rozenfeld, S. T. Fong, L. Komuves, C. Largman, and H. J. Lawrence. 1998. Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. Blood 92:383-393.
24. Jordan, C. T., C. M. Astle, J. Zawadzki, K. Mackarehtschian, I. R. Lemischka, and D. E. Harrison. 1995. Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. Exp. Hematol. 23:1011-1015.
25. Kappen, C. 2000. Disruption of the homeobox gene Hoxb-6 in mice results in increased numbers of early erythrocyte progenitors. Am. J. Hematol. 65: 111-118.
26. Kroon, E., J. Krosl, U. Thorsteinsdottir, S. Baban, A. M. Buchberg, and G. Sauvageau. 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meisla but not Pbx1b. EMBO J. 17:3714-3725.
27. Krosl, J., and G. Sauvageau. 2000. AP-1 complex is effector of Hox-induced cellular proliferation and transformation. Oncogene 19:5134-5141.
28. Kulessa, H., J. Frampton, and T. Graf. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9:1250-1262.
29. Kyba, M., R. C. Perlingeiro, and G. Q. Daley. 2002. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109:29-37.
30. Lawrence, H. J., C. D. Helgason, G. Sauvageau, S. Fong, D. J. Izon, R. K. Humphries, and C. Largman. 1997. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922-1930.
31. a. Lawrence, H. J., S. T. Fong, Y. H. Hsiang, G. Sauvageau, and R. K. Humphries. 1998. Evidence for a stem cell defect in mice with targeted interruption of the Hoxa9 homoebox gene. Blood 92:55a. (Abstract.)
32. - cells with preserved ability to engraft SCID-hu bone. Blood 91:1206-1215.
33. Manley, N. R., and M. R. Capeechi. 1997. Hox group 3 paralogous genes act synergistically in the formation of somitic and neural crest-derived structures. Dev. Biol. 192:274-288.
34. Medina-Martinez, O., A. Bradley, and R. Ramirez-Solis. 2000. A large targeted deletion of Hoxb1-Hoxb9 produces a series of single-segment anterior homeotic transformations. Dev. Biol. 222:71-83.
35. Morrison, A., L. Ariza-McNaughton, A. Gould, M. Featherstone, and R. Krumlauf. 1997. HOXD4 and regulation of the group 4 paralog genes. Development 124:3135-3146.
36. Morrison, S. J., H. D. Hemmati, A. M. Wandycz, and I. L. Weissman. 1995. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 92:10302-10306.
37. Ohta, H., A. Sawada, J. Y. Kim, S. Tokimasa, S. Nishiguchi, R. K. Humphries, J. Hara, and Y. Takihara. 2002. Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J. Exp. Med. 195:759-770.
38. Orkin, S. H. 2000. Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1:57-64.
39. 3 inhibition of c-myc expression. J. Endocrinol. 169: 153-159.
40. 3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. J. Biol. Chem. 274:8437-8444.
41. Pinto Do, O. P., K. Richter, and L. Carlsson. 2002. Hematopoietic progenitor/stem cells immortalized by Lhx2 generate functional hematopoietic cells in vivo. Blood 99:3939-3946.
42. Ramirez-Solis, R., H. Zheng, J. Whiting, R. Krumlauf, and A. Bradley. 1993. Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell 73:279-294.
43. Randall, T. D., and I. L. Weissman. 1997. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89:3596-3606.
44. Rideout, W. M., K. Hochedlinger, M. Kyba, G. Q. Daley, and R. Jaenisch. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109:17-27.
45. Rossel, M., and M. R. Capecchi. 1999. Mice mutant for both Hoxal and Hoxb1 show extensive remodeling of the hindbrain and defects in craniofacial development. Development 126:5027-5040.
46. Saleh, M., I. Rambaldi, X. J. Yang, and M. S. Featherstone. 2000. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol. Cell. Biol. 20:8623-8633.
47. Sauer, B. 1996. Multiplex Cre/lox recombination permits selective site-specific DNA targeting to both a natural and an engineered site in the yeast genome. Nucleic Acids Res. 24:4608-4613.
48. + subpopulations of human bone marrow cells. Proc. Natl. Acad. Sci. USA 91:12223-12227.
49. Sauvageau, G., U. Thorsteinsdottir, C. J. Eaves, H. J. Lawrence, C. Largman, P. M. Lansdorp, and R. K. Humphries. 1995. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1753-1765.
50. Sauvageau, G., U. Thorsteinsdottir, M. R. Hough, P. Hugo, H. J. Lawrence, C. Largman, and R. K. Humphries. 1997. Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 6:13-22.
51. + cells, but impairs lymphomyeloid differentiation. Blood 101:1759-1768.
52. Sharpe, J., S. Nonchev, A. Gould, J. Whiting, and R. Krumlauf. 1998. Selectivity, sharing and competitive interactions in the regulation of Hoxb genes. EMBO J. 17:1788-1798.
53. Shen, W. F., K. Krishnan, H. J. Lawrence, and C. Largman. 2001. The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol. Cell. Biol. 21:7509-7522.
54. Suemori, H., and S. Noguchi. 2000. Hox C cluster genes are dispensable for overall body plan of mouse embryonic development. Dev. Biol. 220:333-342.
55. Szilvassy, S. J., and S. Cory. 1993. Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood 81:2310-2320.
56. Tenen, D. G., R. Hromas, J. D. Licht, and D. E. Zhang. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90:489-519.
57. Thorsteinsdottir, U., A. Mamo, E. Kroon, L. Jerome, J. Bijl, H. J. Lawrence, K. Humphries, and G. Sauvageau. 2002. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99:121-129.
58. Thorsteinsdottir, U., G. Sauvageau, M. R. Hough, W. Dragowska, P. M. Lansdorp, H. J. Lawrence, C. Largman, and R. K. Humphries. 1997. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol. Cell. Biol. 17:495-505.
59. Thorsteinsdottir, U., G. Sauvageau, and R. K. Humphries. 1999. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 94:2605-2612.
60. Thorsteinsdottir, U., G. Sauvageau, and R. K. Humphries. 1997. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol. Oncol. Clin. N. Am. 11:1221-1237.
61. Torres, R. M., and R. Kühn. 1997. Laboratory protocols for conditional gene targeting. Oxford University Press, Oxford, United Kingdom.
62. Varnum-Finney, B., L. Xu, C. Brashem-Stein, C. Nourigat, D. Flowers, S. Bakkour, W. S. Pear, and I. D. Bernstein. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:1278-1281.
63. Zakany, J., and D. Duboule. 1996. Synpolydactyly in mice with a targeted deficiency in the HoxD complex. Nature 384:69-71.
64. Zakany, J. C. Fromental-Ramain, X. Warot, and D. Duboule. 1997. Regulation of number and size of digits by posterior Hox genes: a dose-dependent mechanism with potential evolutionary implications. Proc. Natl. Acad. Sci. USA 94:13695-13700.